A competing risk model provides well-calibrated absolute risk estimates for a first metachronous cutaneous squamous cell carcinoma (cSCC) after an index tumor, according to a study published online ...

Multidisciplinary care is a cornerstone of modern management for high- and very-high-risk cutaneous squamous cell carcinoma ...

Neoadjuvant immunotherapy is expanding treatment options in CSCC by shrinking complex tumors, improving surgical outcomes, ...

SkylineDx, an innovative company specializing in molecular diagnostics for dermatology, today announced the latest research on the company's precision molecular diagnostics advances, including a new ...

Imaging is more sensitive than physical examination for nodal staging of cutaneous squamous cell carcinoma, according to a ...

What factors may put patients at an increased risk of cutaneous squamous cell carcinoma, and what should they know about prevention?

Ultrasound and CT improve nodal staging in high-risk cSCC but show reduced accuracy in immunosuppressed patients. Learn more ...